Teva expects to start paying U.S. opioid settlement in 2023: CEO
Teva Pharmaceutical Industries expects to finalize an opioid settlement in the United States by year-end and start paying in 2023, its CEO said Sunday, while confirming he was unlikely to renew his contract next year.
Teva expects to start paying U.S. opioid settlement in 2023: CEO
Teva Pharmaceutical Industries expects to finalize an opioid settlement in the United States by year-end and start paying in 2023, its CEO said Sunday, while confirming he was unlikely to renew his contract next year.